US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

YD Bio Ltd

11.75

+0.47004.17%

Volume:30.33K

Turnover:348.55K

Market Cap:828.63M

PE:-11.89

High:11.80

Open:11.18

Low:10.81

Close:11.28

52wk High:31.00

52wk Low:5.30

Shares:70.52M

Float Shares:13.27M

Volume Ratio:0.71

T/O Rate:0.23%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.9880

EPS(LYR):-1.2901

ROE:-42.69%

ROA:-25.43%

PB:125.74

PE(LYR):-9.11

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

YD Bio Limited to Acquire Safe Save Medical Cell Sciences & Technology

Yd Bio Limited Enters Into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy

THOMSON REUTERS

Yd Bio Ltd - to Buy Ky Company for US$26.87 Million

THOMSON REUTERS

YD Bio Limited Appoints Dr. Chang and Dr. Lu to Key Board Roles

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/YDES"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"YDES","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"YDES\",,,,,undefined,":{"symbol":"YDES","market":"US","secType":"STK","nameCN":"YD Bio Ltd","latestPrice":11.75,"timestamp":1770669146201,"preClose":11.28,"halted":0,"volume":30328,"delay":0,"changeRate":0.04166666666666673,"floatShares":13265400,"shares":70521359,"eps":-0.988,"marketStatus":"Trading","change":0.47,"latestTime":"02-09 15:34:40 EST","open":11.18,"high":11.8,"low":10.81,"amount":348548.118704,"amplitude":0.087766,"askPrice":11.7,"askSize":3000,"bidPrice":11.15,"bidSize":20,"shortable":3,"etf":0,"ttmEps":-0.988,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770670800000},"marketStatusCode":2,"adr":0,"listingDate":1756440000000,"exchange":"NASDAQ","adjPreClose":11.28,"preHourTrading":{"tag":"盘前","latestPrice":11.02,"preClose":11.28,"latestTime":"08:57 EST","volume":223,"amount":2427.220085,"timestamp":1770645461978,"change":-0.26,"changeRate":-0.02305,"amplitude":0.042553},"postHourTrading":{"tag":"盘后","latestPrice":11.28,"preClose":11.28,"latestTime":"17:42 EST","volume":14,"amount":155.5,"timestamp":1770417756968,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.709046},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"YDES\",,,,,undefined,":{"symbol":"YDES","floatShares":13265400,"roa":"-25.43%","roe":"-42.69%","lyrEps":-1.290101,"volumeRatio":0.709046,"shares":70521359,"dividePrice":0,"high":11.8,"amplitude":0.087766,"preClose":11.28,"low":10.81,"week52Low":5.3,"pbRate":"125.74","psRate":"1623.61","week52High":31,"institutionHeld":0,"latestPrice":11.75,"committee":-0.986755,"eps":-0.988,"divideRate":0,"volume":30328,"delay":0,"ttmEps":-0.988,"open":11.18,"prevYearClose":12.19,"prevWeekClose":11.28,"prevMonthClose":11.87,"prevQuarterClose":12.19,"fiveDayClose":11.47,"twentyDayClose":12.34,"sixtyDayClose":8.84},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/YDES\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-19","symbol":"YDES","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755576000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"YDES\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"YDES\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/YDES\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"YDES","date":"2026-02-06","current":-11.892713,"percent":0.86,"low":-1151.273969,"twenty":-892.723043,"median":-616.73612,"eighty":-563.929958,"high":-416.471241,"avg":-684.25412,"sd":173.159345,"marketCap":756641306},"quantilePoints":[{"date":"2025-09-19","current":-961.968859,"twenty":-999.829881,"median":-916.635267,"eighty":-851.374822,"marketCap":1357875801},{"date":"2025-09-26","current":-709.645075,"twenty":-998.136098,"median":-925.353266,"eighty":-851.374822,"marketCap":1001705892},{"date":"2025-10-03","current":-960.225259,"twenty":-973.028263,"median":-916.635267,"eighty":-851.374822,"marketCap":1355414607},{"date":"2025-10-10","current":-932.078579,"twenty":-963.563007,"median":-911.653554,"eighty":-851.474456,"marketCap":1315683907},{"date":"2025-10-17","current":-939.800234,"twenty":-960.573979,"median":-919.624296,"eighty":-852.27153,"marketCap":1326583479},{"date":"2025-10-24","current":-877.279731,"twenty":-963.563007,"median":-920.745181,"eighty":-864.327276,"marketCap":1238332100},{"date":"2025-10-31","current":-553.468359,"twenty":-960.573979,"median":-906.67184,"eighty":-851.474456,"marketCap":781253244},{"date":"2025-11-07","current":-468.779231,"twenty":-944.084508,"median":-894.715728,"eighty":-771.61759,"marketCap":661709543},{"date":"2025-11-14","current":-504.149397,"twenty":-939.850051,"median":-872.298018,"eighty":-562.236175,"marketCap":711636618},{"date":"2025-11-21","current":-416.471241,"twenty":-935.217058,"median":-854.36385,"eighty":-532.644798,"marketCap":587873728},{"date":"2025-11-28","current":-574.391556,"twenty":-932.875653,"median":-852.122079,"eighty":-497.174998,"marketCap":810787570},{"date":"2025-12-05","current":-636.164802,"twenty":-928.790648,"median":-849.382136,"eighty":-516.703315,"marketCap":897984152},{"date":"2025-12-12","current":-626.201375,"twenty":-924.506374,"median":-777.645464,"eighty":-530.751747,"marketCap":883920187},{"date":"2025-12-19","current":-564.677215,"twenty":-922.364238,"median":-692.707249,"eighty":-539.021391,"marketCap":797075205},{"date":"2025-12-26","current":-621.717833,"twenty":-920.969359,"median":-645.630058,"eighty":-546.593595,"marketCap":877591403},{"date":"2026-01-02","current":-607.270864,"twenty":-919.02649,"median":-636.164802,"eighty":-555.660313,"marketCap":857198654},{"date":"2026-01-09","current":-614.245263,"twenty":-914.642582,"median":-629.688575,"eighty":-564.477946,"marketCap":867043429},{"date":"2026-01-16","current":-568.911671,"twenty":-905.326777,"median":-626.699546,"eighty":-565.524106,"marketCap":803052390},{"date":"2026-01-23","current":-612.750749,"twenty":-899.946527,"median":-622.714176,"eighty":-564.677215,"marketCap":864933835},{"date":"2026-01-30","current":-549.482989,"twenty":-896.708414,"median":-621.717833,"eighty":-564.677215,"marketCap":775627658},{"date":"2026-02-06","current":-536.032363,"twenty":-892.723043,"median":-616.73612,"eighty":-563.929958,"marketCap":756641306}],"updateTime":1770669280736},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"YDES\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2607804390","title":"YD Bio Limited to Acquire Safe Save Medical Cell Sciences & Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2607804390","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607804390?lang=en_us&edition=fundamental","pubTime":"2026-01-29 21:30","pubTimestamp":1769693430,"startTime":"0","endTime":"0","summary":"YD Bio Limited has entered into a binding letter of intent to acquire Safe Save Medical Cell Sciences & Technology Co., Ltd. , a Taiwan-based dendritic cell immunotherapy platform. The agreement involves a combination of newly issued YD Bio Ltd shares and cash, with SSMC's founder and major shareholders set to receive shares through a swap, while other shareholders can choose between cash or shares. Newly issued shares will be subject to lock-up periods of six months for general shareholders and one year for specific shareholders. The transaction aims to accelerate YD Bio Ltd’s expansion into advanced cell and gene therapies, complementing its recent integration of DNA-methylation-driven AI platforms for cancer diagnostics. The acquisition is expected to enhance research and development capabilities and broaden the company’s portfolio in innovative cancer treatment solutions. Completion is subject to due diligence and other customary conditions, with closing targeted shortly after Marc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nNDL3K4XQF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014039.USD","BK4112","IE00BGHQF748.EUR","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BKPKM429.USD","SG9999014021.USD","LU0314104364.USD","LU2210150020.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4585","YDES","LU2095319765.USD","BK4588","BK4139","NDAQ"],"gpt_icon":0},{"id":"2607428080","title":"Yd Bio Limited Enters Into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2607428080","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607428080?lang=en_us&edition=fundamental","pubTime":"2026-01-29 21:30","pubTimestamp":1769693401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nTUA3QTBJL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["YDES","BK4139"],"gpt_icon":0},{"id":"2607080444","title":"Yd Bio Ltd - to Buy Ky Company for US$26.87 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2607080444","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607080444?lang=en_us&edition=fundamental","pubTime":"2026-01-29 21:30","pubTimestamp":1769693401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nTUA3QTBJL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["YDES","BK4139"],"gpt_icon":0},{"id":"2605299105","title":"YD Bio Limited Appoints Dr. Chang and Dr. Lu to Key Board Roles","url":"https://stock-news.laohu8.com/highlight/detail?id=2605299105","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605299105?lang=en_us&edition=fundamental","pubTime":"2026-01-21 19:03","pubTimestamp":1768993421,"startTime":"0","endTime":"0","summary":"YD Bio Limited has appointed Dr. Chang as Chairman of the Compensation Committee and as a member of the Audit Committee and Nominating and Corporate Governance Committee. Dr. Lu has been named Chairman of the Nominating and Corporate Governance Committee and will also serve on the Audit Committee and Compensation Committee. These appointments are effective immediately.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. YD Bio Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 21, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL3ZMD72:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","YDES"],"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/YDES\",params:#limit:6,delay:false,,,undefined,":[]}}